May well have been a good buy on Thursday-Friday last week below 4 cents. Nothing fundamentally has changed rang head office on Friday, spoke to NMR's lovely receptionist who was very positive and excited about events to come (including Chris Mason's attendance at INDABA on 6-8 February). A CR well executed will be a longer-term positive and does not have to be LOWER than current share price. The ability to generate cash relatively quickly, which the scoping study may well determine, will be critical in determining 1. a CR price and 2. Over or under subscription on same.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
13.5¢ |
Change
-0.025(15.6%) |
Mkt cap ! $132.1M | |||
| Open | High | Low | Value | Volume |
| 16.5¢ | 16.5¢ | 13.5¢ | $1.070M | 7.478M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 57339 | 13.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 14.5¢ | 213200 | 2 |
View Market Depth
| Last trade - 16.10pm 25/07/2025 (20 minute delay) ? |
| NMR (ASX) Chart |